Boill Healthcare Holdings Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was HKD 271.65 million compared to HKD 842.28 million a year ago. Net loss was HKD 96.01 million compared to HKD 9.77 million a year ago.

Basic loss per share from continuing operations was HKD 0.0707 compared to HKD 0.0072 a year ago.